MATERIAL EVENT4512.TTSE

Wakamoto Pharmaceutical: change in major shareholder

Summary

WAKAMOTO PHARMACEUTICAL CO., LTD. filed an extraordinary report via EDINET on 2026-01-13 15:40 JST. Reason(s) cited: extraordinary report.

Open the price chart on TradingView.

Source: EDINET S100XF7Y ↗ · PDL1.0 · Not investment advice